Duchenne muscular dystrophy is a genetic condition that primarily affects muscles, but it can also involve the heart. As the condition progresses, changes in the heart muscle may lead to cardiomyopathy, abnormal heart rhythms, or reduced cardiac function. Regular cardiac evaluation is therefore an important part of ongoing care for people with Duchenne muscular dystrophy.
Duchenne muscular dystrophy (DMD) is a genetic disorder associated with progressive muscle weakness caused by changes in the dystrophin gene. Although skeletal muscles are most visibly affected, dystrophin deficiency can also affect cardiac muscle. Heart involvement may develop gradually and sometimes without obvious symptoms in the early stages. For this reason, cardiac monitoring is an important component of comprehensive DMD care.
The heart can become affected as DMD progresses because cardiac muscle cells also require dystrophin for normal structure and function. Damage to these cells may contribute to changes in the heart muscle and its ability to pump blood efficiently.
Common cardiac complications may include:
Some individuals may not experience clear warning signs despite developing cardiac abnormalities. Symptoms such as tiredness, shortness of breath, swelling, or changes in exercise tolerance can have several possible causes and should be evaluated by a healthcare professional.
Because heart complications can develop gradually, regular cardiac assessments are generally recommended for people with DMD. The specific frequency and type of testing depend on age, clinical findings, previous results, and individual circumstances.
Cardiac evaluation may involve:
Early identification of cardiac changes allows healthcare professionals to evaluate appropriate management strategies. Care is often coordinated among neuromuscular specialists, cardiologists, and other healthcare professionals familiar with DMD.
For individuals living with DMD, maintaining scheduled cardiac evaluations is important even when there are no noticeable heart symptoms. Families should discuss any new symptoms or significant changes in physical function with the treating healthcare team.
Duchenne muscular dystrophy can affect the heart as well as skeletal muscles, making cardiovascular monitoring an important part of long-term care. Cardiomyopathy, fibrosis, reduced cardiac function, and abnormal heart rhythms are among the complications that may occur. Regular assessments can help healthcare professionals identify cardiac changes and determine appropriate management. Because heart involvement can progress without obvious symptoms, ongoing evaluation remains important throughout the course of DMD. Information about cardiac complications should be discussed with qualified healthcare professionals who can provide guidance based on an individual's medical history and test results.